160 related articles for article (PubMed ID: 18221093)
1. Role of perindopril in the prevention of stroke.
Papadopoulos DP; Votteas V
Recent Pat Cardiovasc Drug Discov; 2006 Nov; 1(3):283-9. PubMed ID: 18221093
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.
Ferrari R
Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572
[TBL] [Abstract][Full Text] [Related]
3. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
Rapezzi C; Ciliberti P; Graziosi M; Riva L
Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
[TBL] [Abstract][Full Text] [Related]
4. Specific properties and effect of perindopril in controlling the renin-angiotensin system.
Ferrari R; Pasanisi G; Notarstefano P; Campo G; Gardini E; Ceconi C
Am J Hypertens; 2005 Sep; 18(9 Pt 2):142S-154S. PubMed ID: 16125051
[TBL] [Abstract][Full Text] [Related]
5. Trials on blood pressure-lowering and secondary stroke prevention.
Chalmers J
Am J Cardiol; 2003 May; 91(10A):3G-8G. PubMed ID: 12781902
[TBL] [Abstract][Full Text] [Related]
6. Progress in secondary prevention of stroke with PROGRESS. The perindopril protection against recurrent stroke study.
Schiffrin EL
Curr Hypertens Rep; 2002 Feb; 4(1):39-40. PubMed ID: 11790290
[No Abstract] [Full Text] [Related]
7. [Clinical study of the month. Secondary prevention of cerebrovascular accident with perindopril: the PROGRESS study].
Scheen AJ
Rev Med Liege; 2001 Nov; 56(11):792-5. PubMed ID: 11789395
[TBL] [Abstract][Full Text] [Related]
8. The Perindopril Protection Against Recurrent Stroke Study (PROGRESS): clinical implications for older patients with cerebrovascular disease.
Ratnasabapathy Y; Lawes CM; Anderson CS
Drugs Aging; 2003; 20(4):241-51. PubMed ID: 12641480
[TBL] [Abstract][Full Text] [Related]
9. Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation.
Chalmers J; MacMahon S
J Hypertens Suppl; 2003 Jun; 21(5):S9-14. PubMed ID: 12953850
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
Brugts JJ; Ferrari R; Simoons ML
Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
[TBL] [Abstract][Full Text] [Related]
11. Perindopril: an updated review of its use in hypertension.
Hurst M; Jarvis B
Drugs; 2001; 61(6):867-96. PubMed ID: 11398915
[TBL] [Abstract][Full Text] [Related]
12. Evidence for benefits of perindopril in hypertension and its complications.
Laurent S
Am J Hypertens; 2005 Sep; 18(9 Pt 2):155S-162S. PubMed ID: 16125052
[TBL] [Abstract][Full Text] [Related]
13. Ongoing trials of angiotensin-converting enzyme inhibition: what they can tell us.
Chalmers JP
Am J Hypertens; 2001 Aug; 14(8 Pt 2):270S-275S. PubMed ID: 11497208
[TBL] [Abstract][Full Text] [Related]
14. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
Gosse P
Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
[TBL] [Abstract][Full Text] [Related]
15. The PROGRESS trial: questions about the effectiveness of angiotensin converting enzyme inhibitors. Perindopril pROtection aGainst REcurrent Stroke Study.
Psaty BM; Weiss NS; Furberg CD
Am J Hypertens; 2002 May; 15(5):472-4. PubMed ID: 12022252
[No Abstract] [Full Text] [Related]
16. Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan.
Hasegawa Y; Yamaguchi T; Omae T; Woodward M; Chalmers J;
Hypertens Res; 2004 Mar; 27(3):147-56. PubMed ID: 15080373
[TBL] [Abstract][Full Text] [Related]
17. Perindopril for the treatment of hypertension.
Ghiadoni L
Expert Opin Pharmacother; 2011 Jul; 12(10):1633-42. PubMed ID: 21599567
[TBL] [Abstract][Full Text] [Related]
18. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
PROGRESS Collaborative Group
Lancet; 2001 Sep; 358(9287):1033-41. PubMed ID: 11589932
[TBL] [Abstract][Full Text] [Related]
19. Progress in reducing the burden of stroke.
Chalmers J; Chapman N
Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1091-5. PubMed ID: 11903323
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities: should this progress matter to patients?
Schiffrin EL
Circulation; 2005 Sep; 112(11):1525-6. PubMed ID: 16157782
[No Abstract] [Full Text] [Related]
[Next] [New Search]
